Congenital Heart Disease Global Clinical Trials Review, H2, 2013



Summary



GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, H2, 2013" provides data on the Congenital Heart Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Congenital Heart Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Congenital Heart Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Congenital Heart Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Congenital Heart Disease 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Congenital Heart Disease Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Actelion Ltd 35
Clinical Trial Overview of Actelion Ltd 35
Merck and Co., Inc. 36
Clinical Trial Overview of Merck and Co., Inc. 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Asklepion Pharmaceuticals, LLC 38
Clinical Trial Overview of Asklepion Pharmaceuticals, LLC 38
INO Therapeutics, LLC 39
Clinical Trial Overview of INO Therapeutics, LLC 39
ARCA biopharma, Inc. 40
Clinical Trial Overview of ARCA biopharma, Inc. 40
UMC Utrecht Holding BV 41
Clinical Trial Overview of UMC Utrecht Holding BV 41
Novo Nordisk A/S 42
Clinical Trial Overview of Novo Nordisk A/S 42
Abbott Laboratories 43
Clinical Trial Overview of Abbott Laboratories 43
MedImmune, LLC 44
Clinical Trial Overview of MedImmune, LLC 44
Cytori Therapeutics, Inc. 45
Clinical Trial Overview of Cytori Therapeutics, Inc. 45
BG Medicine, Inc. 46
Clinical Trial Overview of BG Medicine, Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
Children's Healthcare of Atlanta Inc. 52
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 52
Emory University 54
Clinical Trial Overview of Emory University 54
University of California, San Francisco 56
Clinical Trial Overview of University of California, San Francisco 56
Medical College of Wisconsin 57
Clinical Trial Overview of Medical College of Wisconsin 57
The Hospital for Sick Children 58
Clinical Trial Overview of The Hospital for Sick Children 58
Boston Children's Hospital 59
Clinical Trial Overview of Boston Children's Hospital 59
Oslo University Hospital 60
Clinical Trial Overview of Oslo University Hospital 60
Competence Network for Congenital Heart Defects 61
Clinical Trial Overview of Competence Network for Congenital Heart Defects 61
The University of Utah 62
Clinical Trial Overview of The University of Utah 62
University of Rochester 63
Clinical Trial Overview of University of Rochester 63
Duke University 64
Clinical Trial Overview of Duke University 64
National Center for Research Resources 65
Clinical Trial Overview of National Center for Research Resources 65
National Taiwan University Hospital 66
Clinical Trial Overview of National Taiwan University Hospital 66
New York University School of Medicine 67
Clinical Trial Overview of New York University School of Medicine 67
Shaare Zedek Medical Center 68
Clinical Trial Overview of Shaare Zedek Medical Center 68
Xijing Hospital 69
Clinical Trial Overview of Xijing Hospital 69
Okayama University 70
Clinical Trial Overview of Okayama University 70
Zekai Tahir Burak Maternity and Teaching Hospital 71
Clinical Trial Overview of Zekai Tahir Burak Maternity and Teaching Hospital 71
Vanderbilt University 72
Clinical Trial Overview of Vanderbilt University 72
Five Key Clinical Profiles 73
Appendix 102
Abbreviations 102
Definitions 102
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106

1.1 List of Tables

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Congenital Heart Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Congenital Heart Disease Therapeutics Clinical Trials, G7 Countries, 2013* 17
Congenital Heart Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Congenital Heart Disease Therapeutics Clinical Trials, E7 Countries, 2013* 19
Congenital Heart Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Congenital Heart Disease Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Congenital Heart Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Congenital Heart Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Congenital Heart Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2013* 35
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 36
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2013* 38
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2013* 39
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013* 40
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2013* 41
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 42
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013* 43
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by MedImmune, LLC, 2013* 44
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2013* 45
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by BG Medicine, Inc., 2013* 46
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 47
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2013* 52
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 54
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 56
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical College of Wisconsin, 2013* 57
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2013* 58
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2013* 59
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2013* 60
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Competence Network for Congenital Heart Defects, 2013* 61
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2013* 62
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 63
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 64
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 65
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 66
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2013* 67
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2013* 68
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Xijing Hospital, 2013* 69
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University, 2013* 70
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Zekai Tahir Burak Maternity and Teaching Hospital, 2013* 71
Congenital Heart Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 72

List of Figures

Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Congenital Heart Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Congenital Heart Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Congenital Heart Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Congenital Heart Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Congenital Heart Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Congenital Heart Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Congenital Heart Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Congenital Heart Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Congenital Heart Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Congenital Heart Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Congenital Heart Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Congenital Heart Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Congenital Heart Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Congenital Heart Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Congenital Heart Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
GlobalData Methodology 104

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • June 2014
  • by Global Data

OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018 Summary Chronic lymphocytic leukemia (CLL), the most common form of adult leukemia, is caused by the uncontrolled ...

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

Multiple Sclerosis (MS) Drugs and Biologics : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research study offers an overview of the multiple sclerosis (MS) disease-modifying product market, including regulatory issues accompanied by detailed analyses and forecasts by product. Its main ...

Sleep Aids : Technologies and Global Markets

Sleep Aids : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

Research on the working of the human brain in relation to sleep is a fairly new area, with many new and novel theories. The discovery of new mechanisms and chemicals in the brain has provided expanding ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.